原话见内
The reported efficacy rates of 94 or 95 percent are for symptomatic disease only. Because the clinical trials for Pfizer and Moderna did not require regular testing for COVID-19, they were not a good indication of how well the vaccine protects against asymptomatic disease (which account for some 40 percent of cases).